Endocrine Abstracts

Background: Oral corticosteroids are a known risk factor for developing osteoporosis and subsequent fracture at higher bone mineral density than post menopausal osteoporosis. Bone loss is thought to be most pronounced in the first 12 weeks of steroid use, and existing guidelines recommend a fracture risk assessment and appropriate osteoporosis prophylaxis with calcium and vitamin D supplements and bisphosphonates. There is also a recognized role for FRAX scoring to help strati...